- Home
- CVV vs TENX Comparison
CVV vs TENX Comparison
Compare CVV & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVV
- TENX
- Stock Information
- Founded
- CVV 1982
- TENX 1967
- Country
- CVV United States
- TENX United States
- Employees
- CVV N/A
- TENX N/A
- Industry
- CVV Industrial Machinery/Components
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- CVV Technology
- TENX Health Care
- Exchange
- CVV Nasdaq
- TENX Nasdaq
- Market Cap
- CVV 20.8M
- TENX 21.7M
- IPO Year
- CVV N/A
- TENX N/A
- Fundamental
- Price
- CVV $3.08
- TENX $6.30
- Analyst Decision
- CVV
- TENX Strong Buy
- Analyst Count
- CVV 0
- TENX 3
- Target Price
- CVV N/A
- TENX $16.00
- AVG Volume (30 Days)
- CVV 17.1K
- TENX 20.7K
- Earning Date
- CVV 03-19-2025
- TENX 05-13-2025
- Dividend Yield
- CVV N/A
- TENX N/A
- EPS Growth
- CVV N/A
- TENX N/A
- EPS
- CVV N/A
- TENX N/A
- Revenue
- CVV $26,876,000.00
- TENX N/A
- Revenue This Year
- CVV N/A
- TENX N/A
- Revenue Next Year
- CVV N/A
- TENX N/A
- P/E Ratio
- CVV N/A
- TENX N/A
- Revenue Growth
- CVV 11.48
- TENX N/A
- 52 Week Low
- CVV $2.70
- TENX $2.77
- 52 Week High
- CVV $6.35
- TENX $7.89
- Technical
- Relative Strength Index (RSI)
- CVV 46.12
- TENX 49.26
- Support Level
- CVV $3.00
- TENX $6.00
- Resistance Level
- CVV $3.13
- TENX $6.76
- Average True Range (ATR)
- CVV 0.14
- TENX 0.40
- MACD
- CVV 0.02
- TENX 0.02
- Stochastic Oscillator
- CVV 20.00
- TENX 39.47
About CVV CVD Equipment Corporation
CVD Equipment Corp is engaged in the manufacturing of chemical vapor deposition equipment, customized gas control systems, the manufacturing of process equipment suitable for the synthesis of a variety of one-dimensional nanostructures and nanomaterials and a line of furnaces, all of which are used to produce semiconductors and other electronic components. The company operates through the segments of CVD Equipment, CVD materials, and Stainless Design Concepts. It generates maximum revenue from the CVD Equipment segment. The CVD Equipment segment manufactures and sells chemical vapor deposition, physical vapor transport, and similar equipment.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.